Jerry Sadoff

1.7k total citations
15 papers, 606 citations indexed

About

Jerry Sadoff is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Jerry Sadoff has authored 15 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Jerry Sadoff's work include Tuberculosis Research and Epidemiology (5 papers), vaccines and immunoinformatics approaches (5 papers) and Immunotherapy and Immune Responses (3 papers). Jerry Sadoff is often cited by papers focused on Tuberculosis Research and Epidemiology (5 papers), vaccines and immunoinformatics approaches (5 papers) and Immunotherapy and Immune Responses (3 papers). Jerry Sadoff collaborates with scholars based in Netherlands, United States and Sweden. Jerry Sadoff's co-authors include Frank Weichold, David A. Edwards, Barry R. Bloom, Willem Andreas Germishuizen, Sunali Goonesekera, Yasir A. W. Skeiky, Donata Sizemore, Markus Maeurer, Raija Ahmed and Benoît Callendret and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Jerry Sadoff

15 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerry Sadoff Netherlands 13 310 245 216 167 99 15 606
Tjarko Meijerhof Netherlands 18 234 0.8× 431 1.8× 333 1.5× 183 1.1× 121 1.2× 25 807
Eric Tsao United States 12 281 0.9× 492 2.0× 86 0.4× 231 1.4× 215 2.2× 22 875
Stéphanie Longet United Kingdom 14 182 0.6× 163 0.7× 231 1.1× 107 0.6× 28 0.3× 24 538
Cynthia Strout United States 8 162 0.5× 337 1.4× 181 0.8× 112 0.7× 18 0.2× 9 553
R D Shahin United States 15 126 0.4× 479 2.0× 258 1.2× 189 1.1× 38 0.4× 25 989
Ross W. Ward Ireland 6 222 0.7× 136 0.6× 241 1.1× 124 0.7× 43 0.4× 12 527
Catherine Hervouet France 15 114 0.4× 155 0.6× 474 2.2× 134 0.8× 25 0.3× 20 777
Chiara Terrosi Italy 16 412 1.3× 228 0.9× 203 0.9× 91 0.5× 84 0.8× 36 797
Elizabeth M. Coyle United States 17 462 1.5× 433 1.8× 204 0.9× 140 0.8× 47 0.5× 21 815
Anthony M. Cadena United States 9 711 2.3× 480 2.0× 280 1.3× 202 1.2× 22 0.2× 11 926

Countries citing papers authored by Jerry Sadoff

Since Specialization
Citations

This map shows the geographic impact of Jerry Sadoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Sadoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Sadoff more than expected).

Fields of papers citing papers by Jerry Sadoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry Sadoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Sadoff. The network helps show where Jerry Sadoff may publish in the future.

Co-authorship network of co-authors of Jerry Sadoff

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry Sadoff. A scholar is included among the top collaborators of Jerry Sadoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry Sadoff. Jerry Sadoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
McLean, Chelsea, Karin Dijkman, Auguste Gaddah, et al.. (2023). Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans. Frontiers in Immunology. 14. 1215302–1215302. 6 indexed citations
2.
Bartsch, Yannic C., Deniz Cizmeci, Jaewon Kang, et al.. (2022). Antibody effector functions are associated with protection from respiratory syncytial virus. Cell. 185(26). 4873–4886.e10. 37 indexed citations
3.
Sadoff, Jerry, Frank Struyf, & Macaya Douoguih. (2021). A Plain Language Summary of How Well the single-dose Janssen Vaccine Works and How Safe It Is. Future Virology. 16(11). 725–739. 2 indexed citations
4.
Williams, Kristi L., Arangassery Rosemary Bastian, Robert Feldman, et al.. (2020). Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years. The Journal of Infectious Diseases. 222(6). 979–988. 79 indexed citations
5.
Churchyard, Gavin, Margaret Ann Snowden, David A. Hokey, et al.. (2015). The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4+ T cell counts >350 cells/mm3. Vaccine. 33(15). 1890–1896. 24 indexed citations
6.
Rahman, Sayma, Isabelle Magalhaes, Jubayer Rahman, et al.. (2012). Prime-Boost Vaccination with rBCG/rAd35 Enhances CD8+ Cytolytic T-Cell Responses in Lesions from Mycobacterium Tuberculosis-Infected Primates. Molecular Medicine. 18(4). 647–658. 31 indexed citations
7.
Magalhaes, Isabelle, Nalini Vudattu, Raija Ahmed, et al.. (2010). High content cellular immune profiling reveals differences between rhesus monkeys and men. Immunology. 131(1). 128–140. 24 indexed citations
8.
Ahmed, Raija, Frank Weichold, Marthie M. Ehlers, et al.. (2010). Human Leukocyte Antigens A*3001 and A*3002 Show Distinct Peptide-Binding Patterns of theMycobacterium tuberculosisProtein TB10.4: Consequences for Immune Recognition. Clinical and Vaccine Immunology. 18(1). 125–134. 13 indexed citations
10.
Magalhaes, Isabelle, Donata Sizemore, Raija Ahmed, et al.. (2008). rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector. PLoS ONE. 3(11). e3790–e3790. 75 indexed citations
11.
Garcia‐Contreras, Lucila, Pavan Muttil, Danielle J. Padilla, et al.. (2008). Immunization by a bacterial aerosol. Proceedings of the National Academy of Sciences. 105(12). 4656–4660. 109 indexed citations
12.
Sampson, Samantha L., Willem Andreas Germishuizen, Sunali Goonesekera, et al.. (2007). Drying a tuberculosis vaccine without freezing. Proceedings of the National Academy of Sciences. 104(8). 2591–2595. 67 indexed citations
13.
Havenga, Menzo, Ronald Vogels, David Zuijdgeest, et al.. (2006). Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells. Journal of General Virology. 87(8). 2135–2143. 78 indexed citations
14.
Nosten, François, C. Luxemburger, Dennis E. Kyle, et al.. (1997). Phase I Trial of the SPf66 Malaria Vaccine in a Malaria-Experienced Population in Southeast Asia. American Journal of Tropical Medicine and Hygiene. 56(5). 526–532. 12 indexed citations
15.
Ballou, W. Ripley, Daniel M. Gordon, D. Gray Heppner, et al.. (1995). Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study. Parasitology. 110(S1). S25–S36. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026